SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparednessKizzmekia S. Corbett, Barney S. Graham, Hamilton Bennett et al.|Nature|2020Cited by 1.7k
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primatesBryan E. Jones, Nicole V. Johnson, Patricia Brown‐Augsburger et al.|Science Translational Medicine|2021Cited by 503
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen PreparednessKizzmekia S. Corbett, Tracy J. Ruckwardt, Darin K. Edwards et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 143